|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�ʸ����˹ϸ�� |
|
��ͷ״��������Ⱦ |
|
��ͷ״������,�� |
| ��������������� | |
|
���� |
|
�浤 |
| PubMed | |
|
Article by |
|
Article by |
�ʸ�˹ϸ����������ͷ��������Ⱦ
����, �浤
�Ͼ�ҽ�ƴ�ѧ��һ����ҽԺƤ���� 210029
�ʸ�˹ϸ���DZ�Ƥ�еĿ�ԭ���ϸ��,������ϵͳ��������Ҫ���á�������ͷ��������Ⱦ��,�ʸ�˹ϸ��������ʶ���δ����Ч������ϸ���鵼�����߷�Ӧ,��Ϊ������ͷ��������Ⱦ�����������ݵIJ���ԭ��,�����ʸ�˹ϸ����������ͷ��������Ⱦ�������ݻ����е����á�
[2] Giannini SL, Hubert P, Doyen J, et al. Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. Int J Cancer, 2002, 97:654-659.
[3] El-Sherif AM, Seth R, Tighe PJ, et al. Decreased synthesis and expression of TGF-beta1, beta2, and beta3 in epithelium of HPV 16-positive cervical precancer: a study by microdissection, quantitative RT-PCR, and immunocytochemistry. J Pathol, 2000, 192:494.
[4] al-Saleh W,Giannini SL,Jacobs N, et al.Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix.J Pathol,1998,184:283-290.
[5] Hubert P, van den Brule F, Giannini SL, et al. Colonization of in vitro-formed cervical human papillomavirus-associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor. Am J Pathol, 1999, 154:775-784.
[6] Sanclemente G, Gill DK. Human papillomavirus molecular biology and pathogenesis. J Eur Acad Dermatol Venereol, 2002, 16:231.
[7] Memar OM, Arany I, Tyring SK. Skin-associated lymphoid tissue in human immunodeficiency virus-1, human papillomavirus, and herpes simplex virus infections. J Invest Dermatol, 1995, 105(1 Suppl): S99- S104.
[8] Sobhani I, Walker F, Aparicio T, et al. Effect of anal epidermoid cancer-related viruses on the dendritic (Langerhans') cells of the human anal mucosa. Clin Cancer Res, 2002, 8:2862-2869.
[9] Coleman N, Birley HD, Renton AM, et al. Immunological events in regressing genital warts. Am J Clin Pathol, 1994, 102:768-774.
[10] Fausch SC, Da Silva DM, Kast WM. Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells. Cancer Res, 2003, 63:3478-3482.
[11] Fausch SC, Da Silva DM, Rudolf MP, et al. Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses.J Immunol, 2002, 169:3242-3249.
[12] Mota F, Rayment N, Chong S, et al. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin Exp Immunol, 1999, 116:33-40.
[13] Connor JP, Ferrer K, Kane JP, et al. Evaluation of Langerhans' cells in the cervical epithelium of women with cervical intraepithelial neoplasia. Gynecol Oncol, 1999, 75:130-135.
[14] Woodworth CD, Simpson S. Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines. Am J Pathol, 1993, 142:1544.
[15] Frazer IH, Thomas R, Zhou J, et al. Potential strategies utilised by papillomavirus to evade host immunity. Immunol Rev, 1999, 168:131-142.
[16] Morelli AE, Sananes C, Di Paola G, et al. Relationship between types of human papillomavirus and Langerhans' cells in cervical condyloma and intraepithelial neoplasia. Am J Clin Pathol, 1993, 99:200-206.